BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30198244)

  • 1. [THE ROLE OF FIBROBLAST GROWTH FACTOR 21 (FGF21) IN THE REGULATION AND CORRECTION OF CARBOHYDRATE AND LIPID METABOLISM].
    Marakova EN; Bazhan NM
    Ross Fiziol Zh Im I M Sechenova; 2016 Dec; 102(12):1406-16. PubMed ID: 30198244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.
    Kralisch S; Fasshauer M
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):354-9. PubMed ID: 21505329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21: from pharmacology to physiology.
    Kliewer SA; Mangelsdorf DJ
    Am J Clin Nutr; 2010 Jan; 91(1):254S-257S. PubMed ID: 19906798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple roles of fibroblast growth factor 21 in metabolism.
    Li LI; Tang L
    Curr Pharm Des; 2015; 21(21):3041-50. PubMed ID: 25675147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FGF21 on glycemic control.
    Strowski MZ
    Horm Mol Biol Clin Investig; 2017 Jun; 30(2):. PubMed ID: 28593912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.
    So WY; Leung PS
    Med Res Rev; 2016 Jul; 36(4):672-704. PubMed ID: 27031294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Physiology of FGF21.
    Fisher FM; Maratos-Flier E
    Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of energy balance by fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA
    Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF21-based pharmacotherapy--potential utility for metabolic disorders.
    Gimeno RE; Moller DE
    Trends Endocrinol Metab; 2014 Jun; 25(6):303-11. PubMed ID: 24709036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF19 subfamily members: FGF19 and FGF21.
    Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
    J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology.
    Li H; Zhang J; Jia W
    Front Med; 2013 Mar; 7(1):25-30. PubMed ID: 23358894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
    Izaguirre M; Gil MJ; Monreal I; Montecucco F; Frühbeck G; Catalán V
    Curr Diab Rep; 2017 Jun; 17(6):43. PubMed ID: 28451950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.
    Zhang F; Yu L; Lin X; Cheng P; He L; Li X; Lu X; Tan Y; Yang H; Cai L; Zhang C
    Mol Endocrinol; 2015 Oct; 29(10):1400-13. PubMed ID: 26308386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases.
    Sonoda J; Chen MZ; Baruch A
    Horm Mol Biol Clin Investig; 2017 May; 30(2):. PubMed ID: 28525362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
    Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
    Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 and its novel association with oxidative stress.
    Gómez-Sámano MÁ; Grajales-Gómez M; Zuarth-Vázquez JM; Navarro-Flores MF; Martínez-Saavedra M; Juárez-León ÓA; Morales-García MG; Enríquez-Estrada VM; Gómez-Pérez FJ; Cuevas-Ramos D
    Redox Biol; 2017 Apr; 11():335-341. PubMed ID: 28039838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.
    Talukdar S; Zhou Y; Li D; Rossulek M; Dong J; Somayaji V; Weng Y; Clark R; Lanba A; Owen BM; Brenner MB; Trimmer JK; Gropp KE; Chabot JR; Erion DM; Rolph TP; Goodwin B; Calle RA
    Cell Metab; 2016 Mar; 23(3):427-40. PubMed ID: 26959184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.